Alpine Partners VI »

Silverback Therapeutics shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $199k 23k 8.51
2021-09-30 $364k 17k 21.97

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Blackrock Muni Intermediate Drtn Fnd (MUI)
Burlington Stores Note 2.250% 4/1
Redfin Corp Note 0.500% 4/0
Blackrock Capital Allocation Trust (BCAT)
Rivian Automotive Note 4.625% 3/1
Stericycle (SRCL)
Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Pagaya Technologies Cl A New (PGY)
Jazz Investments I Note 2.000% 6/1
ON Semiconductor (ON)

View all positions for Alpine Partners VI

Top funds holding Silverback Therapeutics

Deerfield Management Company
RA Capital Management
OrbiMed Advisors
BlackRock
Sr One Capital Management
Vanguard Group
Franklin Resources
State Street Corporation
Geode Capital Management
Nextech Invest
FMR
Woodline Partners
Royce & Associates
Jacobs Levy Equity Management
First Turn Management

View all funds holding Silverback Therapeutics